Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

In 2022, there is a renewed focus on diversity, equity and inclusion (DE&I) in the workplace. But for DE&I to be successful, ...

In many pharma companies, progression of a product (or asset) through development is gated by a series of governance ...

The European Academy of Allergy and Clinical Immunology (EAACI) has launched the first World Anaphylaxis Awareness Day today ...

Pfizer has appointed Chris Boshoff, its current chief oncology officer and executive vice president, as chief scientific ...